Skip to content
Search

Latest Stories

NHS launches new training to expand role of pharmacy technician

The NHS plans to train hundreds of pharmacy staff, expanding their ability to provide advanced clinical services and assume wider roles in dispensing medicines. With a targeted launch in September, up to 840 pharmacy technicians can join in the training programme. The online modules will cover consultation skills, therapeutics, clinical decision-making, assessment skills, and service improvement.

"Community pharmacies are pivotal in local communities, and this novel training scheme empowers them to extend their service offerings to a wider patient base," said Health Minister Neil O'Brien. "Through our investment in the workforce, we're bolstering the implementation of the Pharmacy First initiative with £645 million, ensuring patients have access to expert assistance for various common ailments, including urinary tract infections and earaches."


NHS said the training will offer flexibility to align with the working schedules and prior experience of community pharmacy technicians. It will combine independent online e-course study, educational supervision, and clinical skills training. Facilitated workshops will concentrate on enhancing clinical assessment skills and applying knowledge and skills through case studies, practice activities, and group discussions.

"This comes after the release of the inaugural NHS Long Term Workforce Plan, backed by over £2.4 billion in funding over the next five years," the minister added. "This funding aims to reinforce workforce expansion and allocate resources for added education and training prospects. These efforts encompass the establishment of thousands of additional training roles for pharmacists and a focused endeavour to strengthen the pharmacy technician workforce."

In June, the government introduced an NHS workforce plan to tackle post-COVID-19 staff shortages. Unveiling the 15-year plan, Prime Minister Rishi Sunak stressed its significance as "the most transformative" in NHS staffing. "This is a commitment to investment and change."

Enhancing clinical role to improve patient care

The community pharmacy's aspiration is to further extend the clinical role of its professionals within patient care pathways. This entails offering additional services in prevention, urgent care, and long-term condition management, while actively addressing health disparities in the population, according to NHS.

David Webb David Webb, NHS England's Chief Pharmaceutical Officer

“As with various healthcare professions, pharmacy technicians are expanding their scope to enhance their skills, training, and potential as registered, multi-professional members of healthcare teams,” said David Webb, NHS England's Chief Pharmaceutical Officer. "From 2026, independent prescribing by all new community pharmacists will usher in fresh opportunities, bolstered by novel clinical and technical roles for pharmacy technicians.”

The opportunity for community pharmacy technicians to undertake this post-registration training will build on their existing knowledge and skills as registered healthcare practitioners.

"We are thrilled to provide 840 openings through this program, enhancing the competency and potential of community pharmacy services,” said Matthew Shaw, Director of CPPE. "This expansion involves fortifying the roles of all registered pharmacy team members. Our legacy of fostering teamwork within community pharmacy and involving pharmacy technicians in education continues to yield benefits, ultimately leading to better person-centered care and heightened patient safety."

The NHSE's 2022 Community Pharmacy Workforce Survey revealed a 6 per cent workforce decline across all roles. Pharmacist vacancy rates increased by 16 per cent, indicating heightened reliance on locum pharmacists who work fewer hours on average. The survey also hinted at a possible skills mix change, with a slight rise in pharmacy technicians as accuracy checkers.

More For You

Mike Hewitson, superintendent pharmacist & managing director of Beaminster Pharmacy

Mike Hewitson elected as NPA board member for England

Mike Hewitson elected as NPA board member for England: New term begins April

Mike Hewitson, superintendent pharmacist & managing director ofBeaminster Pharmacy, has been elected as the next National Pharmacy Association (NPA) board member for England.

Since 2023, Hewitson has served as chair of Community Pharmacy Dorset. He is also a member of Somerset Council and a Non-Executive Director at HubRx.

Keep ReadingShow less
Store closures 2024: Chemists among hardest hit

Over 600 chemist shops belonging to multiples and chains were closed last year

Getty Images

35 shops closed per day last year, chemists worst affected

More shops are expected to exit the UK high streets driven by driven by rising operational costs and a continued shift towards online shopping and transactions.

According to figures from PwC, a total of 12,804 outlets operated by chains (those with five or more locations) exited high streets, shopping centres and retail parks in 2024 – equivalent to 35 closures per day.

Keep ReadingShow less
Empty pharmacy shelves due to UK medicine shortages.

The government has said it's investing up to £520m to manufacture more medicines

Pic credit: iStock

Brexit blamed for UK medicine shortages with "little sign of recovery"

The UK is facing “a worsening situation” with drugs shortages compared to the rest of Europe as a result of Brexit, according to the Nuffield Trust health thinktank.

It comes of the back of data that revealed that the department of health and social care (DHSC) received 1,938 notifications of disruptions to medicine supply last year – the highest in four years.

Keep ReadingShow less
Alert! Patients on Promixin should be switched to alternatives by 30 April

Promixin is licensed for treating chronic pulmonary infections caused by Pseudomonas aeruginosa in adults and children with cystic fibrosis

Getty Images

Medicine shortage: Promixin to be discontinued from May 2025

The Department of Health and Social Care (DHSC) and NHS England have issued a national patient safety alert regarding the upcoming shortage of Promixin (colistimethate).

The alert, issued on 17 March 2025, states that Promixin (colistimethate) 1-million-unit powder for nebuliser solution unit dose vials (UDVs) will be discontinued from early May 2025, with stocks expected to be exhausted by this time.

Keep ReadingShow less
PAGB welcomes new vice-presidents and treasurer to Board

Rob Elliott and Bas Vorsteveld ( L-R)

Bas Vorsteveld will now oversee the Kenvue’s business in Northern Europe

PAGB appoints new vice-presidents and treasurer to Board

PAGB, the consumer healthcare association, has announced the appointment of two new vice-presidents and a treasurer to their Board.

Bas Vorsteveld, area managing director for Northern Europe at Kenvue, and Rob Elliott, OTC centre of excellence lead at Viatris, have been elected as vice-presidents.

Keep ReadingShow less